Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension
This research is investigating a new way to help diagnose pulmonary hypertension, a condition where the blood vessels in the lungs become narrow, making it hard for the heart to pump blood. The study aims to use a simple, low-cost breath test (called capnography) to measure the amount of carbon dioxide in a person's exhaled breath. Because pulmonary hypertension affects the lungs, it changes how breath comes out. Researchers believe these changes can be picked up by the breath test. They want to find a specific 'cut-off' value from this test that could quickly indicate if someone might have pulmonary hypertension. This could help doctors identify people who need further tests sooner, potentially leading to earlier diagnosis and treatment.
At a glance
What is this study about?
This study is looking into a condition called pulmonary hypertension. This isn't just high blood pressure in your arm; it's high blood pressure specifically in the arteries that go from your heart to your lungs. Over time, the tiny blood vessels in the lungs can become narrower and stiffer, making it harder for blood to flow through. This makes your heart work much harder and can lead to serious problems.
Currently, diagnosing pulmonary hypertension can involve complex and sometimes uncomfortable procedures. That's why this research is trying to find a simpler, non-invasive method. They're focusing on a breath test that measures carbon dioxide as you exhale. When the blood vessels in your lungs change due to pulmonary hypertension, it can affect how your body deals with gases like carbon dioxide. Researchers hope to find a specific level of carbon dioxide in your breath that acts as a signal for the condition.
The main goal is to see if this breath test can help doctors discover who might have pulmonary hypertension earlier. If successful, this simple test could be used alongside other diagnostic tools. It would be an easy and inexpensive way to help decide if someone needs more detailed investigations, potentially speeding up diagnosis and helping people get the right treatment sooner.
Key takeaways
- Looks for a simple breath test to help diagnose pulmonary hypertension.
- Uses a non-invasive capnography device to measure exhaled carbon dioxide.
- Aims to find a 'cut-off' value for early detection of the condition.
- Could lead to a quicker, cheaper way to identify patients needing further tests.
- Participation involves having your breath measured during a planned heart procedure.
- Does not involve new medications or extra hospital visits.
Who may be eligible?
To be considered for this study, you need to be an adult, aged 18 years or older. The doctors must also suspect that you might have pulmonary hypertension. This 'suspicion' means that your medical team thinks this condition could be the cause of your symptoms, and they are already planning, or have recently carried out, a special heart test called a right heart catheterization.
Apart from these criteria, there aren't any specific reasons that would stop someone from joining the study. If you meet the age and suspicion criteria, you could be a good fit.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do your doctors suspect you might have pulmonary hypertension?
- Are you scheduled for, or have you recently had, a right heart catheterization?
- Are you willing to have your breath measured during this procedure?
What does participation involve?
If you join this study, the main thing you'll be asked to do is have your breath measured. This will be done using a device called a capnograph, which simply measures the carbon dioxide in your exhaled breath. This is a quick and non-invasive test, similar to breathing into a tube.
This breath measurement will happen at the same time as you are having a 'right heart catheterization'. This is a standard procedure that doctors use to get a clear picture of the pressure in the heart and lung arteries. You won't be given any new medications specifically as part of this study, nor will there be any extra follow-up visits just for research purposes. The study measurements will be integrated with your existing medical care, and the total duration for your participation would simply be the time it takes for your breath measurement during the planned catheterization.
Potential risks and benefits
Locations (1)
- University Clinic Giessen and MarburgVerified postcodeGiessen, Germany
Common questions
What is pulmonary hypertension?
It's a serious condition where the blood pressure in the arteries leading from your heart to your lungs is too high, making your heart work harder.
What is capnography?
It's a simple, non-invasive test that measures the amount of carbon dioxide in your breath as you exhale.
Why are researchers studying my breath?
Changes in your lung blood vessels due to pulmonary hypertension can affect the carbon dioxide in your breath, and researchers want to see if this can help with diagnosis.
Will this test diagnose me immediately?
No, this study aims to find a 'cut-off' value for future diagnosis. It's a research tool right now, not a direct diagnostic test for you personally.
Are there any side effects from the breath test?
No, the breath test itself is very safe and does not have any known side effects.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.